Advances in Chronic Kidney Disease
Volume 11, Issue 2 , Pages 228-233 , April 2004

Promise or peril? impact of the medicare drug benefit on the ESRD population

  • Mark E Williams

      Affiliations

    • Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA
    • Corresponding Author InformationAddress correspondence to Mark E. Williams, MD, FACP, Harvard Medical School, 1 Joslin Place, Boston, MA 02215 USA

References 

  1. O’Toole TP. Treating high blood pressure (A test of evidence-based medicine). Adv Stud Med. 2003;3:296–298
  2. Tozawa M, Iseki K, Iseki CH, et al.  Analysis of drug prescription in chronic hemodialysis patients. Nephrol Dial Transplant. 2002;17:1819–1824
  3. Agarwal R, Nissenson AR, Batlle D, et al.  Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. Am J Med. 2003;115:291–297
  4. Sambamoorthi U, Shea D, Crystal S. Total and out-of-pocket expenditures for prescription drugs among older persons. Gerontologist. 2003;43:345–359
  5. Madrick J. Health for sale. New York Review. 2003;50:71–74
  6. Starfield B. Primary care visits and health policy. Can Med Assoc J. 1998;159:795–796
  7. Druss BG, Marcus SC, Olfson M, et al.  Comparing the national economic burden of five chronic conditions. Health Aff. 2001;20:233–241
  8. Russell LB, Wolff N. The impact of drug pricing policies on the health of the elderly. Am J Prev Med. 2002;22:151–155
  9. Shih YT. Effect of insurance on prescription drug use by ESRD beneficiaries. Health Care Finan Rev. Spring 1999;20(3):39–54
  10. Iglehart JK. Medicare and prescription drugs. N Engl J Med. 2001;344:1010–1015
  11. United States Renal Data System . Researcher’s Guide to the USRDS Database. Bethesda, MD: National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1998;
  12. Thomas CP. Incentive-based formularies. N Engl J Med. 2003;349:2186–2188
  13. Plante CL. 1971 Medicare amendment (Reflections on the passage of the end-stage renal disease Medicare program). Am J Kidney Dis. 2000;35(suppl 4):S45–S48
  14. Paganini EP. The end-stage renal disease program (Experience with a chronic disease capitated health plan). Infect Dis Clin North Am. 2001;15:7211–7729
  15. U.S. Renal Data System . USRDS 2003 Annual Data Report. Bethesda MD: National Institutes of Health, National Institute of Diabetes and Digestisve and Kidney Diseases; 2003;
  16. Hirth RA, Tedeschi PJ, Wheeler JRC. Extent and sources of geographic variation in Medicare end-stage renal disease expenditures. Am J Kidney Dis. 2001;38:824–831
  17. Eggars PW. A quarter century of Medicare expenditures for ESRD. Semin Nephrol. 2000;20:516–522
  18. Sullivan SD. The cost effectiveness of mycophenolate mofetil in the first year after primary cadaveric transplant. J Am Soc Nephr. 1997;8:1592–1598
  19. Cooper RS, Durazo-Arvizu R. Hypertension detection and control (Population and policy implications). Cardiol Clin. 2002;20:187–194
  20. Levin A. Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis. Semin Dial. 2003;16:101–105
  21. D’Amico M, Locatelli F. Hypertension in dialysis (Pathophysiology and treatment). J Nephrol. 2002;15:438–445
  22. Collins AJ, Kasiske B, Herzog C, et al.  Excerpts from the United States renal data system 2003 (Atlas of end-stage renal disease in the United States). Am J Kidney Dis. 2003;42(suppl 5):A5–A7
  23. Horl MP, Horl WH. Hypertension and dialysis. Kidney Blood Press Res. 2003;26:76–81
  24. Morse SA, Dang A, Thakur V, et al.  Hypertension in chronic dialysis patients (Pathophysiology, monitoring, and treatment). Am J Med Sci. 2003;325:194–201
  25. Zoccali C, Mallamaci F, Tripepi G. Traditional and emerging cardiovascular risk factors in end-stage renal disease. Kidney Int. 2003;85(suppl):S105–S110
  26. Zager PG, Nikolic J, Brown RH, et al.  “U” curve association of blood pressure and mortality in hemodialysis patients. Kidney Int. 1998;54:561–569
  27. Griffith TF, Chua B, Allen AS, et al.  Characteristics of treated hypertension in incident hemodialysis and peritoneal dialysis patients. Am J Kidney Dis. 2003;42:1260–1269

PII: S1073-4449(04)00013-5

doi: 10.1053/j.arrt.2004.02.002

Advances in Chronic Kidney Disease
Volume 11, Issue 2 , Pages 228-233 , April 2004

Article Tools

* Image Usage & Resolution